Immunome (IMNM) Change in Account Payables (2019 - 2026)

Immunome has reported Change in Account Payables for 8 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 137.3% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$3.9 million (down 218.46% YoY), and the FY2025 full-year result was -$9.2 million, down 196.2% from the prior year.
• Change in Account Payables for Q1 2026 stood at $1.4 million, up from -$2.3 million in the prior quarter.
• The five-year high for Change in Account Payables was $9.3 million in Q4 2024, with the low at -$4.9 million in Q2 2025.
• Historically, Change in Account Payables has averaged $29294.1 across 5 years, with a median of -$32000.0 in 2024.
• Annual changes were most pronounced in 2024 — Change in Account Payables soared 1465.24% — and 2025, when it slumped 15362.5%.
• Immunome's Change in Account Payables stood at -$739000.0 in 2022, then grew by 8.12% to -$679000.0 in 2023, then soared by 1465.24% to $9.3 million in 2024, then tumbled by 124.56% to -$2.3 million in 2025, then soared by 162.41% to $1.4 million in 2026.
• The last three Change in Account Payables figures came in at $1.4 million (Q1 2026), -$2.3 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.